Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada

Lancet Gastroenterol Hepatol. 2022 Apr;7(4):288-289. doi: 10.1016/S2468-1253(22)00054-1. Epub 2022 Feb 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Inflammatory Bowel Diseases* / epidemiology
  • Ontario / epidemiology
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines